COMMUNIQUÉS West-GlobeNewswire

Orphazyme A/S: New share-based incentive programme
16/11/2017
Company announcement Orphazyme A/S No. 8/2017 Ole Maaløes Vej 3 DK-2200 Copenhagen N www.orphazyme.com Company Registration No. 32266355 16 November 2017 With reference to the offering circular (the "Offering Circular [...]
Orphazyme A/S: Stabilisation period begins
16/11/2017
Company announcement Orphazyme A/S No. 7/2017 Ole Maaløes Vej 3 DK-2200 Copenhagen N www.orphazyme.com Company Registration No. 32266355 16 November 2017 NOT FOR RELEASE OR DISTRIBUTION OR PUBLICATION IN WHOLE OR IN [...]
What You Need to Know About Winter Allergies
16/11/2017
ASHEVILLE, N.C., Nov. 16, 2017 (GLOBE NEWSWIRE) -- What’s lurking indoors during the ‘non-allergy’ season? Traditionally, most people associate the spring and fall months with ‘allergy season’. Although trees, grasses [...]
Summit Therapeutics plc : Miscellaneous
16/11/2017
Summit Therapeutics plc ("Summit" or the "Company") SUMMIT APPOINTS PANMURE GORDON AS JOINT BROKER Oxford, UK, 16 November 2017- Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) the drug discovery and development [...]
ABLYNX ANNOUNCES RESULTS FOR THE FIRST NINE MONTHS OF 2017 AND A YEAR-TO-DATE BUSINESS UPDATE
16/11/2017
REGULATED INFORMATION Positive Phase III results with caplacizumab and a successful U.S. IPO GHENT, Belgium, 16 November 2017 - Ablynx NV [Euronext Brussels and Nasdaq: ABLX] today announced its non-audited financial [...]
TiGenix announces approval of trade name for lead development candidate Cx601 in Europe
16/11/2017
PRESS RELEASE TiGenix announces approval of trade name for lead development candidate Cx601 in Europe International Nonproprietary Name (INN), darvadstrocel, approved for Cx601 Leuven (BELGIUM) - November 16, 2017, 7h: [...]
TiGenix annonce l'approbation d'un nom commercial en Europe pour son produit candidat en phase de développement, le Cx601
16/11/2017
COMMUNIQUÉ DE PRESSE TiGenix annonce l'approbation d'un nom commercial en Europe pour son produit candidat en phase de développement, le Cx601 Darvadstrocel est la dénomination commune internationale (DCI) approuvée [...]
Orphazyme announces the result of its IPO, including an offer price of DKK 80 per share
16/11/2017
Company announcement Orphazyme A/S No. 5/2017 Ole Maaløes Vej 3 DK-2200 Copenhagen N www.orphazyme.com Company Registration No. 32266355 16 November 2017 NOT FOR RELEASE OR DISTRIBUTION OR PUBLICATION IN WHOLE OR IN [...]
Orphazyme A/S: Election of new members of the Board of Directors
16/11/2017
Company announcement Orphazyme A/S No. 4/2017 Ole Maaløes Vej 3 DK-2200 Copenhagen N www.orphazyme.com Company Registration No. 32266355 16 November 2017 On 16 November 2017, Orphazyme A/S ("Orphazyme") held an [...]
Arsanis Announces Pricing of Initial Public Offering
16/11/2017
WALTHAM, Mass. and VIENNA, Austria, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Arsanis, Inc., a clinical-stage biopharmaceutical company focused on applying monoclonal antibody immunotherapies to address serious infectious [...]
Achillion Announces Pricing of Secondary Offering Of Common Stock
16/11/2017
NEW HAVEN, Conn., Nov. 15, 2017 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (“Achillion”) (NASDAQ: ACHN ) today announced the pricing of an underwritten public offering of 18,367,346 shares of its common stock [...]
Loop Industries provides update on the Montreal facility
15/11/2017
MONTREAL, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Loop Industries, Inc. (OTCQX:LLPP), a leader in sustainably produced polyethylene terephthalate (Polyester/PET) resin, announced today that following its due diligence review [...]
AxoGen, Inc. Announces Proposed Public Offering of Common Stock
15/11/2017
ALACHUA, Fla., Nov. 15, 2017 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for the repair of peripheral nerve damage, announced today that it [...]
EDAP TMS Reports Third Quarter 2017 Results
15/11/2017
EDAP TMS Reports Third Quarter 2017 Results EDAP's HIFU patient treatment revenues grew 29% compared to third quarter 2016. EDAP received FDA clearance for its Ablatherm Fusion ® late in the quarter. EDAP's cash [...]
MacroGenics Names Dr. Jay Siegel to its Board of Directors
15/11/2017
ROCKVILLE, MD, Nov. 15, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Allscripts to deliver anaesthesiology solution at the Royal Adelaide Hospital
15/11/2017
ADELAIDE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ) has been appointed by South Australia Health to deliver its anaesthesia information management system (AIMS) at the Royal Adelaide [...]
Allscripts to deliver anesthesiology solution at the Royal Adelaide Hospital
15/11/2017
ADELAIDE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ) has been appointed by South Australia Health to deliver its anesthesia information management system (AIMS) at the Royal Adelaide [...]
Spring Bank Pharmaceuticals Announces Positive Top-Line Results from the Second Cohort of Part A of the Phase 2 ACHIEVE Trial
15/11/2017
Low Dose of Inarigivir Soproxil (50mg) Monotherapy Demonstrates a Favorable Safety Profile and Significant Dose-Dependent Antiviral Activity, Meeting Both Primary Endpoints Conference Call Scheduled for Tomorrow, Nov. [...]
K2M Group Holdings, Inc. to Participate in the 29th Annual Piper Jaffray Healthcare Conference
15/11/2017
LEESBURG, Va., Nov. 15, 2017 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]

Pages